HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


German Nutraceuticals Market Growth Slows In 2022 But Vitamin C Remains Popular

Executive Summary

The growth of sales of nutraceuticals through German pharmacy is slowing post-pandemic, according to IQVIA data. However, there were still double-digit gains for vitamin C and multivitamin products.

You may also be interested in...

Japan’s Theravalues Clinical Trial Claims Curcumin Benefits For Common Cold

Japanese curcumin specialist Theravalues claims to have found via a randomized clinical trial that its Theracurmin and Theracurmin Super dietary supplements can help alleviate some symptoms of the common cold. “However, the level of evidence is weak,” they warn. “Additionally, because the study was based on the reporting of subjective cold-like symptoms, it is was unclear whether the symptoms were actual subjective symptoms caused by an upper respiratory tract infection.”

German Wellness Launches: Stada And Klinge Introduce Electrolytes, Orthomol Targets Aging

New OTC products on the German market: Stada extends its Elotrans line with an electrolyte supplement aimed at sporty and social youth; Klinge also launches an electrolyte product, but as a food for special medical purposes for diarrhea sufferers; and Orthomol introduces a multinutrient supplement to help people age healthily. 

With Bricks-And-Mortar Launch, Sons Wants To Be UK’s Number-One OTC Hair Loss Brand

With the help of Ceuta Healthcare, Irish men's health specialist Careforsons is launching its hair loss treatments in UK Superdrug stores. CEO William Kennedy talks to HBW Insight about the transition from the direct-to-consumer, online, subscription-based model to the bricks-and-mortar channel, and how the company intends to differentiate itself from category incumbents like Kenvue's Regaine and Dr Wolff's Alpecin. 


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts